| Year |
Citation |
Score |
| 2020 |
Asleh K, Brauer HA, Sullivan A, Lauttia S, Lindman H, Nielsen TO, Joensuu H, Thompson EA, Chumsri S. Predictive biomarkers for adjuvant capecitabine benefit in early stage triple negative breast cancer in the FinXX clinical trial. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32005747 DOI: 10.1158/1078-0432.CCR-19-1945 |
0.32 |
|
| 2014 |
Brauer HA, D'Arcy M, Libby TE, Thompson HJ, Yasui YY, Hamajima N, Li CI, Troester MA, Lampe PD. Dermcidin expression is associated with disease progression and survival among breast cancer patients. Breast Cancer Research and Treatment. 144: 299-306. PMID 24562771 DOI: 10.1007/S10549-014-2880-3 |
0.4 |
|
| 2011 |
Brauer HA, Libby TE, Mitchell BL, Li L, Chen C, Randolph TW, Yasui YY, Lampe JW, Lampe PD. Cruciferous vegetable supplementation in a controlled diet study alters the serum peptidome in a GSTM1-genotype dependent manner. Nutrition Journal. 10: 11. PMID 21272319 DOI: 10.1186/1475-2891-10-11 |
0.399 |
|
| 2010 |
Brauer HA, Lampe PD, Yasui YY, Hamajima N, Stolowitz ML. Biochips that sequentially capture and focus antigens for immunoaffinity MALDI-TOF MS: a new tool for biomarker verification. Proteomics. 10: 3922-7. PMID 20957758 DOI: 10.1002/Pmic.201000219 |
0.379 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2018 |
Brauer HA, Mashadi-Hossein A, Buckingham W, Danaher P, Ferree S. Gene expression signature development to decode breast cancer heterogeneity. Journal of Clinical Oncology. 36: e24243-e24243. DOI: 10.1200/jco.2018.36.15_suppl.e24243 |
0.294 |
|
| 2020 |
Swain SM, Tang G, Brauer HA, Goerlitz DS, Lucas PC, Robidoux A, Harris BT, Bandos H, Ren Y, Geyer CE, Rastogi P, Mamounas EP, Wolmark N. NSABP B-41, a Randomized Neoadjuvant Trial: Genes and Signatures Associated with Pathologic Complete Response. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32371537 DOI: 10.1158/1078-0432.Ccr-20-0152 |
0.286 |
|
| 2020 |
Schroth W, Büttner FA, Kandabarau S, Hoppe R, Fritz P, Kumbrink J, Kirchner T, Brauer HA, Ren Y, Henderson DA, Madden SF, Sauer G, Fehm T, Wallwiener D, Fasching PA, et al. Gene expression signatures of BRCAness and tumor inflammation define subgroups of early-stage hormone receptor-positive breast cancer patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 33008814 DOI: 10.1158/1078-0432.CCR-20-1923 |
0.284 |
|
| 2019 |
Waks AG, Stover DG, Guerriero JL, Dillon DA, Barry WT, Gjini E, Hartl CA, Lo WT, Savoie J, Brock J, Wesolowski R, Li Z, Damicis A, Philips AV, Wu Y, ... ... Brauer HA, et al. The immune microenvironment in hormone receptor-positive breast cancer before and after preoperative chemotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31061067 DOI: 10.1158/1078-0432.Ccr-19-0173 |
0.278 |
|
| 2019 |
Chumsri S, Asleh K, Brauer HA, Hinerfeld D, Kachergus JM, Lauttia S, Lindman H, Nielsen T, Joensuu H, Thompson EA. Effects of immune architecture on response to adjuvant capecitabine in triple-negative breast cancer (FinXX trial). Journal of Clinical Oncology. 37: 3142-3142. DOI: 10.1200/JCO.2019.37.15_SUPPL.3142 |
0.273 |
|
| 2012 |
Brauer HA, Makowski L, Hoadley KA, Lang LJ, Freemerman AJ, Perou CM, Troester MA. Impact of stromal microenvironment on metabolic phenotypes in breast cancer: evidence for stroma-influenced Warburg effect Bmc Proceedings. 6. DOI: 10.1186/1753-6561-6-S3-P8 |
0.267 |
|
| 2013 |
Brauer HA, Makowski L, Hoadley KA, Casbas-Hernandez P, Lang LJ, Romàn-Pèrez E, D'Arcy M, Freemerman AJ, Perou CM, Troester MA. Impact of tumor microenvironment and epithelial phenotypes on metabolism in breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 571-85. PMID 23236214 DOI: 10.1158/1078-0432.Ccr-12-2123 |
0.262 |
|
| 2018 |
Force JM, Abbott S, Broadwater G, Stashko I, Westbrook KE, Kimmick GG, Sammons SL, Hyslop T, Brauer HA, Mashadi-Hossein A, Plichta JK, Hwang ES, Kauff ND, Weinhold KJ, Nair S, et al. Immune profiling of BRCA-mutated breast cancers. Journal of Clinical Oncology. 36: 585-585. DOI: 10.1200/Jco.2018.36.15_Suppl.585 |
0.257 |
|
| 2013 |
Casbas-Hernandez P, D'Arcy M, Roman-Perez E, Brauer HA, McNaughton K, Miller SM, Chhetri RK, Oldenburg AL, Fleming JM, Amos KD, Makowski L, Troester MA. Role of HGF in epithelial-stromal cell interactions during progression from benign breast disease to ductal carcinoma in situ. Breast Cancer Research : Bcr. 15: R82. PMID 24025166 DOI: 10.1186/Bcr3476 |
0.252 |
|
| 2022 |
Chumsri S, Li Z, Serie DJ, Norton N, Mashadi-Hossein A, Tenner K, Brauer HA, Warren S, Danaher P, Colon-Otero G, Partridge AH, Carey LA, Hilbers F, Van Dooren V, Holmes E, et al. Adaptive immune signature in HER2-positive breast cancer in NCCTG (Alliance) N9831 and NeoALTTO trials. Npj Breast Cancer. 8: 68. PMID 35610260 DOI: 10.1038/s41523-022-00430-0 |
0.236 |
|
| 2019 |
Lee JS, Yost SE, Blanchard S, Schmolze D, Yin HH, Pillai R, Robinson K, Tang A, Martinez N, Portnow J, Wen W, Yim JH, Brauer HA, Ren Y, Luu T, et al. Phase I clinical trial of the combination of eribulin and everolimus in patients with metastatic triple-negative breast cancer. Breast Cancer Research : Bcr. 21: 119. PMID 31703728 DOI: 10.1186/s13058-019-1202-4 |
0.226 |
|
| 2023 |
Carter JM, Chumsri S, Hinerfeld DA, Ma Y, Wang X, Zahrieh D, Hillman DW, Tenner KS, Kachergus JM, Brauer HA, Warren SE, Henderson D, Shi J, Liu Y, Joensuu H, et al. Distinct spatial immune microlandscapes are independently associated with outcomes in triple-negative breast cancer. Nature Communications. 14: 2215. PMID 37072398 DOI: 10.1038/s41467-023-37806-0 |
0.222 |
|
| 2019 |
Stemmer SM, Shvartser Y, Shemesh II, Peretz I, Yerushalmi R, Hendler D, Haviv I, Brauer HA, Castro M. Investigating the utility of breast cancer (BC) molecular signatures and immune signature profiling (ISP) as predictors of pathological complete response (pCR) to neoadjuvant chemotherapy + trastuzumab (NAC+T) in HER2+ BC. Journal of Clinical Oncology. 37: e12109-e12109. DOI: 10.1200/JCO.2019.37.15_SUPPL.E12109 |
0.221 |
|
| 2021 |
Robinson TJ, Wilson LE, Marcom PK, Troester M, Lynch CF, Hernandez BY, Parrilla E, Brauer HA, Dinan MA. Analysis of Sociodemographic, Clinical, and Genomic Factors Associated With Breast Cancer Mortality in the Linked Surveillance, Epidemiology, and End Results and Medicare Database. Jama Network Open. 4: e2131020. PMID 34714340 DOI: 10.1001/jamanetworkopen.2021.31020 |
0.211 |
|
| 2012 |
Sampey BP, Freemerman AJ, Zhang J, Kuan PF, Galanko JA, O'Connell TM, Ilkayeva OR, Muehlbauer MJ, Stevens RD, Newgard CB, Brauer HA, Troester MA, Makowski L. Metabolomic profiling reveals mitochondrial-derived lipid biomarkers that drive obesity-associated inflammation. Plos One. 7: e38812. PMID 22701716 DOI: 10.1371/Journal.Pone.0038812 |
0.145 |
|
| 2004 |
Lim MY, Wang H, Kapoun AM, O'connell M, O'Young G, Brauer HA, Luedtke GR, Chakravarty S, Dugar S, Schreiner GS, Protter AA, Higgins LS. p38 Inhibition attenuates the pro-inflammatory response to C-reactive protein by human peripheral blood mononuclear cells. Journal of Molecular and Cellular Cardiology. 37: 1111-4. PMID 15572041 DOI: 10.1016/j.yjmcc.2004.09.015 |
0.083 |
|
| 2020 |
Crotty R, Hu K, Stevenson K, Pontius MY, Sohani AR, Ryan RJH, Rueckert E, Brauer HA, Hudson B, Berlin AM, Rodenbaugh M, Licon A, Haimes J, Iafrate AJ, Nardi V, et al. Simultaneous Identification of Cell of Origin, Translocations, and Hotspot Mutations in Diffuse Large B-Cell Lymphoma Using a Single RNA-Sequencing Assay. American Journal of Clinical Pathology. PMID 33258912 DOI: 10.1093/ajcp/aqaa185 |
0.078 |
|
| Hide low-probability matches. |